Health Care

Database for Dietary Ingredient Content of Dietary Supplements

Scientists from the Agricultural Research Service’s (ARS) Nutrient Data Laboratory, part of the Beltsville Human Nutrition Research Center, and the National Institutes of Health’s (NIH) Office of Dietary Supplements, in collaboration with other federal agencies, earlier this year updated and released a database that validates the content of popular dietary supplements — the Dietary Supplement […]

Database for Dietary Ingredient Content of Dietary Supplements Read More »

The Public Isn’t Buying What the CPSC Is Selling

By former CPSC Commissioner Nancy Nord The U.S. Consumer Product Safety Commission (CPSC) may want to help people sleep better at night, but their actions are more likely to keep people up or give them nightmares.  This past week the CPSC re-announced a recall of portable, adult bed handles because the original announcement garnered such a low response

The Public Isn’t Buying What the CPSC Is Selling Read More »

EPA Hazardous Waste Pharmaceuticals Rule Begins Circulating: Proposal Applies To Dietary Supplements, 503B Outsourcing Facilities, And Any OTC Retailers

On Tuesday, the Environmental Protection Agency (EPA) announced that its Administrator signed the proposed rule: Management Standards for Hazardous Waste Pharmaceuticals Rule.  The announcement and EPA blog post are here.   The summary of the pre-publication proposed rule is available here and the 267-page proposal is available for download here.  EPA is expected to publish the

EPA Hazardous Waste Pharmaceuticals Rule Begins Circulating: Proposal Applies To Dietary Supplements, 503B Outsourcing Facilities, And Any OTC Retailers Read More »

Privacy Update: Refill Reminders Expressly Permitted In California – The State Finally Catches Up to the Feds

Although HIPAA-compliant sponsored “refill reminders” have always been legally permissible for a host of treatments under California’s Confidentiality of Medical Information Act (CMIA), Cal. Civ. Code §§ 56-56.37, the state finally came right out and said so. California’s Office of Health Information Integrity (CalOHII), just published its long-awaited State Health Information Policy Manual (“Manual” or

Privacy Update: Refill Reminders Expressly Permitted In California – The State Finally Catches Up to the Feds Read More »

Device Firms: What You Should Know About The 21st Century Cures Act

Last month, legislation that would affect, among other things, FDA’s regulation of medical devices and the manufacturers of such devices took a considerable step forward when it was introduced and then unanimously approved by the House Energy and Commerce Committee by a vote of 51-0 on May 21.  Known as the 21st Century Cures Act (“Act”),

Device Firms: What You Should Know About The 21st Century Cures Act Read More »

May 19 Webinar on the Drug Supply Chain Security Act

Tish Eggleston Pahl will be speaking on May 19 at a webinar on dispenser obligations under the Drug Supply Chain Security Act (DSCSA).  The webinar is sponsored by the Healthcare Distribution Management Association (HDMA).  This “DSCSA Overview for Dispensers” continues HDMA’s education and outreach on the pharmacy and hospital–related implementation requirements under the DSCSA.  Particular focus

May 19 Webinar on the Drug Supply Chain Security Act Read More »

2015 Dietary Guidelines Advisory Committee Report Mixes Science and Policy

The 2015 Dietary Guidelines Advisory Committee (DGAC) submitted its report to the Secretaries of Agriculture and Health and Human Services last month and disbanded.  It is now up to the USDA and HHS to take the DGAC’s conclusions and recommendations and issue a revised edition of the Dietary Guidelines for Americans.  Interested persons may submit

2015 Dietary Guidelines Advisory Committee Report Mixes Science and Policy Read More »

Webinar: Drug Supply Chain Security Act Overview for Dispensers

On April 21, OFW Law’s Tish Eggleston Pahl will participate in a webinar being held by the Healthcare Distribution Management Association (HDMA) for dispensers on implementation of the Drug Supply Chain Security Act (DSCSA) Register Today! Learn what is expected of dispensers as it relates to the DSCSA through a HDMA webinar on Tuesday, April 21 from 2:00–3:00

Webinar: Drug Supply Chain Security Act Overview for Dispensers Read More »

Dietary Guidelines – Confused About Caffeine

The news wires have been buzzing lately about the recently released scientific report of the Dietary Guidelines Advisory Committee. One of the hottest topics for discussion is how out of step the report is on a number of issues, including the Committee’s dive into political matters like sustainability, soda taxes, and “added sugar” labeling. These

Dietary Guidelines – Confused About Caffeine Read More »

Privacy Update: White House Drops Draft Consumer Privacy Bill . . . Splat!

The White House (via the Department of Commerce) has released a “discussion draft” of consumer privacy legislation intended to codify President Obama’s 2012 Consumer Data Privacy In A Networked World: A Framework For Protecting Privacy And Promoting Innovation In The Global Digital Economy.  The 2012 Framework included a Consumer Privacy Bill of Rights and called

Privacy Update: White House Drops Draft Consumer Privacy Bill . . . Splat! Read More »

Drug Supply Chain Security Act – What’s Next? A whole lot.

The passage of the Drug Supply Chain Security Act (DSCSA) in November 2013 led to a very busy 2014 as FDA and manufacturers, wholesale distributors, and dispensers began the statute’s complex 10-year implementation.  2015 promises to be equally busy. A Surge Of Activity At Year-End In 2014 2014 closed in a flurry of DSCSA action. 

Drug Supply Chain Security Act – What’s Next? A whole lot. Read More »

Statement by Senator Bob Dole on Nutrition Report

Contact: Marshall Matz (202) 789-1212; mmatz@ofwlaw.com or Marion Watkins (202) 654-4863; marion.watkins@alston.com “As co-author with Senator George McGovern of the original 1977 ‘Dietary Goals for the United States’ report, I commend the USDA, HHS and its Dietary Guidelines Advisory Committee for continuing to focus attention on human nutrition.  The Committee’s recently-released report notes the staggering numbers of

Statement by Senator Bob Dole on Nutrition Report Read More »

Fred Branding headshot

FDA’s Draft Guidance On DSCSA Preemption Misses The Mark

In a flurry of end-of-year activity, FDA recently issued a Draft Guidance on the express preemption provisions in §585 of the FDC Act, added last year by the Drug Supply Chain Security Act (or DSCSA). FDA, the pharmaceutical supply chain, and other stakeholders have been working very hard to implement the DSCSA as quickly as

FDA’s Draft Guidance On DSCSA Preemption Misses The Mark Read More »

FTC Reminds Us That HHS’s Office for Civil Rights Not Only One Watching Medical Privacy

Seasons greetings from the Federal Trade Commission (FTC). Yesterday, the FTC published its Agreement Containing Consent Order and attendant press release regarding its settlement with a medical billing company (PaymentsMD) and the company CEO for alleged failure to adequately inform patients regarding the company’s collection of their medical records.  Although not arising under HIPAA (which

FTC Reminds Us That HHS’s Office for Civil Rights Not Only One Watching Medical Privacy Read More »

Webinar Tomorrow: What Dispensers Need to Know About the Drug Supply Chain Security Act

A Complimentary Webinar Presented by OFW Law’s Tish Pahl and the Food Marketing Institute Thursday, December 4th, 2014 3:00 pm – 4:00 pm US/Eastern Please join FMI on a webinar with Tish Pahl —Under the Drug Supply Chain Security Act (DSCSA), beginning January 1, 2015, manufacturers, wholesaler drug distributors, and repackagers, must provide transaction data

Webinar Tomorrow: What Dispensers Need to Know About the Drug Supply Chain Security Act Read More »

The DSCSA Standards Guidance is here!

This morning, FDA met another of its milestones in implementing the Drug Supply Chain Security Act (DSCSA) and posted a Draft Guidance, DSCSA Standards for the Interoperable Exchange of Information for Tracing of Certain Human, Finished, Prescription Drugs: How to Exchange Product Tracing Information.  FDA is to be commended for both getting the Draft Guidance

The DSCSA Standards Guidance is here! Read More »

Consumer-Directed Promotions About Prescription Drugs: A Look Back at Print and TV Communications

OFW Law Celebrates 35 Years of Successes in Drug/Healthcare Privacy Practices (Part VI) By Tish Eggleston Pahl In celebrating 35 years of practice, OFW Law’s Drugs, Biologics, and Controlled Substances and Healthcare Privacy practice groups are taking a look back to share some highlights throughout the years.  Parts I, II, III, IV and V focus on

Consumer-Directed Promotions About Prescription Drugs: A Look Back at Print and TV Communications Read More »

GMPs Have Long History That Precedes Application In Medical Products

OFW Law Celebrates 35 Years of Successes in Drug/Healthcare Privacy Practices (Part V) By Neil P. Di Spirito In celebrating 35 years of practice, OFW Law’s Drugs, Biologics, and Controlled Substances and Healthcare Privacy practice groups are taking a look back to share some highlights throughout the years.  Parts I, II, III, and IV focused on

GMPs Have Long History That Precedes Application In Medical Products Read More »

26 Years, With 9 To Go…. 35 Years to Prescription Drug Traceability

OFW Law Celebrates 35 Years of Successes in Drug/Healthcare Privacy Practices (Part IV) By Tish Eggleston Pahl In celebrating 35 years of practice, OFW Law’s Drugs, Biologics, and Controlled Substances and Healthcare Privacy practice groups are taking a look back to share some highlights throughout the years.  Parts I, II, and III focused on Hatch-Waxman, medical

26 Years, With 9 To Go…. 35 Years to Prescription Drug Traceability Read More »

John Block headshot

The Realized Benefits of User Fees

OFW Law Celebrates 35 Years of Successes in Drug/Healthcare Privacy Practices (Part III) In celebrating 35 years of practice, OFW Law’s Drugs, Biologics, and Controlled Substances and Healthcare Privacy practice groups are taking a look back to share some highlights throughout the years. Parts I and II focused on Hatch-Waxman and medical privacy laws, while

The Realized Benefits of User Fees Read More »

HIPAA Comes of Age… Thanks to HITECH, D.D.S.

OFW Law Celebrates 35 Years of Successes in Drug/Healthcare Privacy Practices (Part II) In celebrating 35 years of practice, OFW Law’s Drugs, Biologics, and Controlled Substances and Healthcare Privacy practice groups are taking a look back to share some highlights from throughout the years.  Part I focused on Hatch-Waxman.  Today’s blog focuses on the development

HIPAA Comes of Age… Thanks to HITECH, D.D.S. Read More »

Thirty Years of Hatch Waxman

OFW Law Celebrates 35 Years of Successes in Drug/Healthcare Privacy Practices (Part I) Since its inception in 1979, OFW Law’s Drugs, Biologics, and Controlled Substances and Healthcare Privacy practices have focused on myriad regulatory issues arising under FDA and broader HHS jurisdiction.  We advise clients on matters ranging from Hatch-Waxman and generic drug marketing exclusivity

Thirty Years of Hatch Waxman Read More »

The Next Dietary Guidelines Debate

By Marshall L. Matz and Nathaniel B. Fretz, as published by Agri-Pulse There is a new question surrounding the Dietary Guidelines for Americans now being drafted for release in 2015. The question is whether the Dietary Guidelines Advisory Committee should continue to focus their review and recommendations on scientific advances in nutrition and diet or should they venture

The Next Dietary Guidelines Debate Read More »

Marshall Matz headshot

Following the Money: House And Senate Appropriations Release Draft Bills & Reports Funding FDA For FY 2015

The House and Senate Appropriations Committees with oversight of FDA have been very busy. Both voted out draft bills for FY 2015 that include appropriations for FDA and released draft reports.  Roger Szemraj and the rest of our government relations practice have scoured the draft bills and reports looking for insight into what FDA drug-related activities

Following the Money: House And Senate Appropriations Release Draft Bills & Reports Funding FDA For FY 2015 Read More »

Kenneth Ackerman

HHS Releases HIPAA Security Rule Risk Assessment Tool

The Department of Health and Human Services’ (HHS) Office for Civil Rights (OCR), Office of the National Coordinator for Health Information Technology (ONC), and Office of the General Counsel (OGC), have released their Security Risk Assessment (SRA) tool.  The SRA tool is designed to assist Covered Entities and their Business Associates (BA) ensure compliance with

HHS Releases HIPAA Security Rule Risk Assessment Tool Read More »

CPSC Proposes to Make Voluntary Recalls and Compliance Programs Legally Binding

On November 13, 2013, the U.S. Consumer Product Safety Commission (CPSC) issued a proposed interpretive rule concerning corrective action plans for “voluntary” recalls that may impact future voluntary consumer product recalls in two significant ways.   First, CPSC proposes to make voluntary recall agreements that companies negotiate with CPSC legally binding.  Second, CPSC proposes to permit

CPSC Proposes to Make Voluntary Recalls and Compliance Programs Legally Binding Read More »

HHS Guidance Expands Scope of Refill Reminders and Reasonable Costs

As we reported recently, the Department of Health and Human Services (HHS) announced its intent to issue guidance regarding prescription “refill reminder” programs that can be conducted without patient authorization by September 23, 2013.  HHS’s Office for Civil Rights (OCR) actually beat that deadline by four days, publishing its Guidance on September 19, 2013. OCR’s

HHS Guidance Expands Scope of Refill Reminders and Reasonable Costs Read More »